GAO Asked to Study GPOs’ Possible Role in Drug Shortages

by Admin | November 19, 2012 9:48 am

November 19, 2012—Six influential House Democrats have asked the Government Accountability Office (GAO) to investigate whether group purchasing organization (GPO) contracting practices have caused drug shortages that, in turn, have forced hospitals and other providers to rely on compounding pharmacies to obtain medicines at reasonable cost.

The Nov. 15 request[1] came amid hearings last week on the deadly nationwide meningitis outbreak linked to contaminated injectable drugs produced by a Massachusetts-based compounding pharmacy. 

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2].    Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

 

Endnotes:
  1. The Nov. 15 request: http://markey.house.gov/press-release/markey-top-democrats-call-gao-investigation-link-between-drug-shortages-and-increased
  2. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  3. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2012/11/gao-asked-to-study-gpos-possible-role-in-drug-shortages/

Copyright ©2026 340binformed.org unless otherwise noted.